[Cavernous hemangioma and disseminated intravascular coagulation (Kasabach-Merritt syndrome) in a newborn infant with a large ventricular septal defect].
In a 3170 g newborn with a large cavernous hemangioma at the left thigh, heart failure was evident. Echo- and angiographically a large perimembranous ventricular septal defect was found. An important a-v shunt within the hemangioma could be excluded by hemodynamic investigation and selective arteriographic examination of the vascular tumor. Thrombocytopenia present from the first day of life was only temporarily overcome by corticosteroid therapy but nevertheless consumption coagulopathy (Kasabach-Merritt-Syndrome) developed and additional therapy with heparin was necessary in order to normalize the coagulation factors. However, no regression in size of the tumor occurred over the first 8 weeks of life and a total exstirpation of the hemangioma was performed. Postoperatively no further cortison or heparin therapy was necessary. Despite vigorous medical treatment the congestive heart failure persisted. After surgical closure of the ventricular septal defect at the age of three months the infant thrived and could be discharged without pathological symptoms.
D006328:Cardiac Catheterization; D003131:Combined Modality Therapy; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis* / Q000628:therapy; D004359:Drug Therapy, Combination; D004452:Echocardiography; D006345:Heart Septal Defects, Ventricular / Q000175:diagnosis* / Q000628:therapy; D006392:Hemangioma, Cavernous / Q000175:diagnosis* / Q000628:therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010976:Platelet Count / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000628:therapy
D006493:Heparin; D011241:Prednisone
Kavernöses Hämangiom und Verbrauchskoagulopathie (Kasabach-Merritt-Syndrom) bei einem Neugeborenen mit einem grossen Ventrikelseptumdefekt.